257 essays 1,087 funds measured independent · not paid by any fund or issuer we cover

Fund · Invesco S&P MidCap Quality ETF · measured from SEC filings

XMHQ holdings

XMHQ reports 81 holdings and behaves like 54.1 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-07-31. The fact sheet publishes the first number; this page computes the second, and traces it across 27 quarters of filings.

Measured concentration

as of 2026-07-31

Read this figure with the following in mind

10.5% of net assets is securities-lending cash collateral, excluded from the figure; counted as filed the fund would read 39.8

The figure below is what the filing says, published unchanged. What it may not do is sit beside a plain long-only fund and be read as the same quantity. How comparability is decided.

81 Positions reported
54.1 Effective holdings
1.5× Concentration multiple
31.61% Top ten weight

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 90.47% at a quoted market price (level 1), 5 issuer countries.

What stands out

as of 2026-07-31

XMHQ's largest investment is TechnipFMC PLC at 4.95% of net assets. United Therapeutics Corp and Illumina Inc follow; the three together are 12.48%. Ten companies are 31.61% of the fund; the other 71 share the rest. Among the 721 equity funds measured here, XMHQ behaves like 54.1 holdings against a median of 42.4 — close to the median. Across 27 quarterly filings XMHQ has held roughly steady since 2019-10-31 (58.3 then, 52.6 now). the United States is the largest country at 89.12% of the portfolio, across 5 countries in the filing.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Every filing since 2019

27

Between 2019-10-31 and 2026-04-30, XMHQ went from behaving like 58.3 equally weighted positions to 52.6 — 10% fewer, while its top ten went from 27.19% to 30.99% of net assets. Read across the funds on the concentration-over-time table.

PeriodHoldingsEffective Top 10Largest
2026-04-30 81 52.6 30.99% 4.95%
2026-01-31 81 55.5 29.33% 4.09%
2025-10-31 78 50.9 31.8% 5.67%
2025-07-31 80 53.9 30.2% 5.28%
2025-04-30 79 57.9 28.21% 4.28%
2025-01-31 80 54.7 30.5% 5.13%
2024-10-31 78 56.9 28.57% 4.02%
2024-07-31 81 60.3 26.5% 3.94%
Earlier filings (19 more, back to 2019-10-31)
PeriodHoldingsEffectiveTop 10Largest
2024-04-30 78 58.6 27.34% 3.83%
2024-01-31 80 57.8 27.99% 4.64%
2023-10-31 78 58 28.34% 4.32%
2023-07-31 81 60.2 27.22% 4.39%
2023-04-30 80 64.9 24.39% 3.2%
2023-01-31 80 68 22.13% 2.88%
2022-10-31 80 64.7 24.94% 3.83%
2022-07-31 80 66.3 23.8% 3.15%
2022-04-30 78 63.1 24.25% 3.32%
2022-01-31 80 61.4 25.75% 4.5%
2021-10-31 78 54.7 29.93% 4.89%
2021-07-31 81 57.4 29.2% 4.57%
2021-04-30 77 59.2 26.14% 3.47%
2021-01-31 80 61 26.1% 3.55%
2020-10-31 77 54.3 29.33% 4.54%
2020-07-31 80 53.3 30.79% 4.85%
2020-04-30 79 54.9 29.65% 3.8%
2020-01-31 81 59.7 26.23% 3.54%
2019-10-31 78 58.3 27.19% 3.86%

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

As filed, collateral included

10.54% collateral

XMHQ's filing lists 83 positions including 10.54% of net assets in securities-lending cash collateral. Counted as filed the fund reads 39.8 effective holdings with a top ten of 36.94%; on its own investments — the figure above — it reads 54.1 with a top ten of 31.61%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.

Largest positions, as filed

as of 2026-04-30

The 15 largest of 81 positions in XMHQ's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: XMHQ.csv.gz.

#PositionWeightCumulative
1TechnipFMC PLC4.95%5.0%
2United Therapeutics Corp.3.98%8.9%
3Illumina, Inc.3.55%12.5%
4Twilio Inc.3.00%15.5%
5Carlisle Cos. Inc.2.74%18.2%
6Carpenter Technology Corp.2.72%20.9%
7Sterling Infrastructure, Inc.2.61%23.5%
8Medpace Holdings, Inc.2.54%26.1%
9Nextpower Inc.2.53%28.6%
10Royal Gold, Inc.2.38%31.0%
11BWX Technologies, Inc.2.35%33.3%
12Talen Energy Corp.2.22%35.6%
13Exelixis, Inc.2.13%37.7%
14Lincoln Electric Holdings, Inc.1.99%39.7%
15Alcoa Corp.1.94%41.6%

By country of issuer

as of 2026-04-30

Share of XMHQ's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

CountryShare
United States 91.12%
United Kingdom 4.95%
Bermuda° 3.07%
Ireland° 0.86%

Returns the fund reported

2019-08 – 2026-04

Monthly total returns from Item B.5 of XMHQ's own filings, 81 months on record. Not computed here and not from a price feed.

16.8%Last twelve months filed
136%Whole series, compounded
13.8%Best month
-12.8%Worst month

Cross-checked against a series computed separately from prices: median difference 0.12 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: XMHQ.json · all funds.

Who borrows XMHQ's shares

2026-07-31

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-07-31, $562m was out to 25 borrowers. The largest, CITIGROUP GLOBAL MARKETS INC., held 20.8% of it.

BorrowerOn loanShare of the loan
CITIGROUP GLOBAL MARKETS INC. $117m 20.8%
GOLDMAN SACHS & CO. $93m 16.6%
MORGAN STANLEY & CO LLC $69m 12.3%
JP MORGAN SECURITIES LLC $56m 10.0%
BofA Securities, Inc. $49m 8.7%

The filing reports no cash collateral position against this loan. Collateral taken in a form the fund does not hold as a position does not appear in N-PORT, so this is silence rather than absence. What the collateral figure can and cannot show. Every quarter XMHQ has filed, with each borrower: XMHQ.json · all funds.

Since the previous filing

2026-01-31 → 2026-04-30

81 positions became 81: 0 added (0.0% of the fund at the later date), 0 dropped (0.0% at the earlier date). Half the sum of all weight changes, a turnover proxy: 6.5%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of XMHQ compared this way, as a feed: changes.xml · all funds: filings received.

Largest increases2026-01-312026-04-30Largest decreases2026-01-312026-04-30
TechnipFMC PLC3.68%4.95% Medpace Holdings, Inc.3.56%2.54%
Sterling Infrastructure, Inc.1.83%2.61% Illumina, Inc.4.09%3.55%
Carpenter Technology Corp.2.03%2.72% Royal Gold, Inc.2.71%2.38%
United Therapeutics Corp.3.30%3.98% Hamilton Lane Inc.0.90%0.58%
Twilio Inc.2.46%3.00% Kinsale Capital Group, Inc.1.47%1.19%
Alcoa Corp.1.74%1.94% Doximity, Inc.0.77%0.50%

Asset categories and pricing

as of 2026-07-31

90.41% equity, 9.59% short-term investment as filed; 90.5% carried at a quoted market price (fair-value level 1). Categories and levels are the filer's; what a low level-1 share does and does not mean is in the measure's page.

Neighbours by effective holdings, equity funds

10

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of XMHQ (54.1). Same filings, same arithmetic. Position in this list says nothing about which fund is better.

FundReportsBehaves likeTop tenAs of
OSCV Opus Small Cap Value ETF 65 52.8 27.73% 2026-07-31
FLEU Franklin FTSE Eurozone ETF 260 53.2 29.22% 2026-06-30
VONE Vanguard Russell 1000 Index Fund 1,011 53.5 36.38% 2026-05-31
SCHK Schwab 1000 Index ETF 989 53.5 36.24% 2026-05-31
APIE ActivePassive International Equity ETF 548 53.5 23.91% 2026-05-31
IFRA iShares U.S. Infrastructure ETF 164 54.4 32.36% 2026-06-30
CGGE Capital Group Global Equity ETF 115 54.6 34.07% 2026-05-31
XMMO Invesco S&P MidCap Momentum ETF 76 54.8 28.92% 2026-07-31
IYY iShares Dow Jones U.S. ETF 967 54.8 35.04% 2026-07-31
XT iShares Future Exponential Technologies ETF 214 55.1 33.58% 2026-07-31

Essays that examine XMHQ

0

Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.